Debt (Tables)

9 Months Ended

Sep. 30, 2014

Debt Instrument [Line Items]

Schedule of principal amounts, unamortized discount and net carrying amounts

The following table sets forth information related to the 2033 Senior Notes which is included our Condensed Consolidated Balance Sheets:

(In thousands)	Embedded conversion option			2033 Senior Notes			Discount			Total
Balance at December 31, 2013	$	101,087		$	158,064		$	(47,239	)	$	211,912
Amortization of debt discount	—			—			4,596			4,596
Change in fair value of embedded derivative	(3,291		)	—			—			(3,291		)
Conversion	(47,353		)	(70,422		)	19,441			(98,334		)
Balance at September 30, 2014	$	50,443		$	87,642		$	(23,202	)	$	114,883

Summary of lines of credit

The following table summarizes the amounts outstanding under the Chilean and Spanish lines of credit:

(Dollars in thousands)			Balance Outstanding
Lender	Interest rate on borrowings at September 30, 2014	Credit line capacity	September 30, 2014	December 31, 2013
Itau Bank	6.52%	$1,800	$927	$1,999
Bank of Chile	6.34%	2,250	1,386	2,079
BICE Bank	6.16%	1,700	887	516
Corp Banca	—%	—	—	(47)
BBVA Bank	5.00%	2,000	1,241	523
Penta Bank	7.34%	1,200	1,007	946
Security Bank	6.16%	640	806	1,075
BCI	—%	—	—	198
Estado Bank	5.30%	2,800	1,507	1,772
Sabadell Bank	4.50%	190	—	—
Bilbao Vizcaya Bank	4.72%	317	—	—
Santander Bank	4.50%	254	—	—
Total		$13,151	$7,761	$9,061

Farmadiet Acquisition

Debt Instrument [Line Items]

Schedule of principal amounts, unamortized discount and net carrying amounts

At September 30, 2014 and December 31, 2013, we had mortgage notes and other debt related to OPKO Health Europe as follows:

(In thousands)	September 30, 2014		December 31, 2013
Current portion of notes payable	$	492	$	1,964
Other long-term liabilities	2,627		3,270
Total mortgage notes and other debt	$	3,119	$	5,234

Notes

Debt Instrument [Line Items]

Inputs to lattice model used to value the embedded derivative

The following table sets forth the inputs to the lattice model used to value the embedded derivative:

	September 30, 2014
Stock price	$8.51
Conversion Rate	141.4827
Conversion Price	$7.07
Maturity date	February 1, 2033
Risk-free interest rate	1.55%
Estimated stock volatility	45%
Estimated credit spread	883 basis points

Fair value of notes with and without the embedded derivatives and fair value of embedded derivatives

The following table sets forth the fair value of the 2033 Senior Notes with and without the embedded derivatives, and the fair value of the embedded derivatives at September 30, 2014. At September 30, 2014 the principal amount of the 2033 Senior Notes was $87.6 million:

(In thousands)	September 30, 2014
Fair value of 2033 Senior Notes:
With the embedded derivatives	$	116,597
Without the embedded derivatives	$	66,154
Estimated fair value of the embedded derivatives	$	50,443